2m 2m 2m 2m 2m 2m 2m
ALIGOS THERAPT (ALGS)
NASDAQ
$6.60-$0.07 (-1.11%)
Price as of Aug 21, 2026 7:32 PM EDT- $36.3MMarket Cap
- -34.61%1-Year Change
- BiotechnologyIndustry
ALIGOS THERAPT (ALGS)
$6.60-$0.07 (-1.11%)
ALGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.67 | ||
Change | +$0.23 (+3.57%) | ||
Open | $6.48 | ||
High | $6.80 | ||
Low | $6.40 | ||
Previous Close | $6.44 | ||
Volume | 52,329 | ||
30-Day Average Volume | 147,248 | ||
1-Week Change | -3.19% | ||
1-Month Change | 22.61% | ||
1-Year Change | -34.61% | ||
3-Year Change | -70.36% | ||
5-Year Change | -98.24% | ||
Fundamentals | |||
Shares Outstanding | 5.4M | ||
Total Assets | $66.3M | ||
Market Cap | $36.3M | ||
Enterprise Value | $5.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$1.5M | ||
Free Cash Flow | -$24.9M | ||
EBIT | $1.3M | ||
EBITDA | $1.6M | ||
Net Working Capital | $33.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -48 | ||
PEG | -1 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/19/2024 | ||
Earnings & Revenue